FSLSX
Price
$51.57
Change
+$0.63 (+1.24%)
Updated
Jun 6 closing price
Net Assets
1.65B
JVMCX
Price
$26.03
Change
+$0.25 (+0.97%)
Updated
Jun 6 closing price
Net Assets
21.45B
Interact to see
Advertisement

FSLSX vs JVMCX

Header iconFSLSX vs JVMCX Comparison
Open Charts FSLSX vs JVMCXBanner chart's image
Fidelity Value Strategies
Price$51.57
Change+$0.63 (+1.24%)
VolumeN/A
Net Assets1.65B
JHancock Disciplined Value Mid Cap C
Price$26.03
Change+$0.25 (+0.97%)
VolumeN/A
Net Assets21.45B
FSLSX vs JVMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSLSX vs. JVMCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLSX is a Buy and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 21.5B vs. FSLSX (1.65B). FSLSX pays higher dividends than JVMCX: FSLSX (0.81) vs JVMCX (0.00). FSLSX was incepted earlier than JVMCX: FSLSX (41 years) vs JVMCX (14 years). JVMCX (1.88) is less costly to investors than FSLSX (0.80). FSLSX is a more actively managed with annual turnover of: 61.00 vs. JVMCX (47.00). FSLSX has a lower initial minimum investment than JVMCX: FSLSX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -4.66 vs. FSLSX (-11.03). FSLSX return over 5 years is better than : 56.72 vs. JVMCX (33.39).
FSLSXJVMCXFSLSX / JVMCX
Total Expense Ratio0.801.8743%
Annual Report Gross Expense Ratio0.801.8843%
Fund Existence41 years14 years-
Gain YTD-6.8911.897-363%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B21.5B8%
Annual Yield % from dividends0.810.00-
Returns for 1 year-11.03-4.66237%
Returns for 3 years-0.191.47-13%
Returns for 5 years56.7233.39170%
Returns for 10 years16.2225.9662%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIO31.580.57
+1.84%
ALPS Medical Breakthroughs ETF
FTXL87.420.37
+0.43%
First Trust Nasdaq Semiconductor ETF
VUSB49.61-0.01
-0.02%
Vanguard Ultra-Short Bond ETF
XPP24.45-0.05
-0.22%
ProShares Ultra FTSE China 50
PCRB48.16-0.25
-0.52%
Putnam ESG Core Bond ETF